MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 44 filers reported holding MYMD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,429 | -60.5% | 59,846 | 0.0% | 0.00% | – |
| Q2 2023 | $89,769 | -13.1% | 59,846 | -0.4% | 0.00% | – |
| Q1 2023 | $103,355 | +62.4% | 60,090 | +8.6% | 0.00% | – |
| Q4 2022 | $63,659 | -55.8% | 55,356 | 0.0% | 0.00% | – |
| Q3 2022 | $144,000 | +22.0% | 55,356 | +2.2% | 0.00% | – |
| Q2 2022 | $118,000 | -53.2% | 54,151 | 0.0% | 0.00% | – |
| Q1 2022 | $252,000 | -26.5% | 54,151 | -4.3% | 0.00% | – |
| Q4 2021 | $343,000 | -15.7% | 56,561 | 0.0% | 0.00% | – |
| Q3 2021 | $407,000 | +180.7% | 56,561 | +145.4% | 0.00% | – |
| Q2 2021 | $145,000 | – | 23,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NorthRock Partners, LLC | 1,354,004 | $9,749,000 | 0.80% |
| Shay Capital LLC | 197,184 | $1,420,000 | 0.18% |
| Corundum Group, Inc. | 11,240 | $81,000 | 0.06% |
| Mirae Asset Global Investments Co., Ltd. | 1,132,131 | $8,151,000 | 0.02% |
| Patriot Financial Group Insurance Agency, LLC | 500 | $4,000 | 0.00% |
| MORGAN STANLEY | 668,151 | $4,811,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,956 | $21,000 | 0.00% |
| NORTHERN TRUST CORP | 56,561 | $407,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 279 | $2,000 | 0.00% |